TrialAntiviral chemistry & chemotherapy

Incidence of CXCR4 tropism and CCR5-tropic resistance in treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1 and 2 trials.

Becky Jubb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.